-
Published04/03/2025
-
Deadline07/04/2025
-
Opening of tenders07/04/2025
-
Today21/04/2025
Utilities
- indicates text translated automatically in your browsing language
Generic replacement funds 24 Text automatically translated in your browsing language Automatically translated
The subject of the tender is the conclusion of drug-related discount agreements pursuant to § 130a(8) SGB V on medicinal products for 24 months from 01.01.2026 - 31.12.2027. The contracts refer in each case to all the medicinal products that are the subject of the contract, which are supplied during the term of the contract to the detriment of the health insurance funds. In principle, only prescription-only medicinal products are in demand per lot. In principle, the call for tenders is based on active substances within the meaning of Section 24b(2) of the AMG, not within the meaning of Section 4(19) of the AMG. 209 lots were formed. These are each divided into so-called exchange groups. The DAK-G is authorised by the other substitute funds to carry out the call for tenders in their name and with effect. More details can be found in the procurement documents. Text automatically translated in your browsing language Automatically translated
https://www.dtvp.de/Satellite/notice/CXP4YM55463
https://www.dtvp.de/Satellite/notice/CXP4YM55463
hkk - Handelskrankenkasse
HEK - Hanseatische Krankenkasse
TK - Techniker Krankenkasse
KKH - Kaufmännische Krankenkasse
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.